Pharmaceutical manufacturing facility capital investment
Total planned capital expenditure and investment in pharmaceutical manufacturing and fill-finish facilities.
Unit million USD Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Pharmaceutical manufacturing facility capital investment
United States, as of 20 Aug 2026
Every record
All records
1 record · 1 region · 2026
| Period | Value | Source | Type |
|---|---|---|---|
| United States 1 record | |||
| as of 20 Aug 2026 | 750 million USD | Roche · 20 Aug 2026 | forecast |
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Roche’s US subsidiary Genentech announces manufacturing expansion in the United States | Roche | 20 Aug 2026 | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Pharmaceutical manufacturing facility capital investment. Retrieved from https://statorigin.org/indicators/pharmaceutical-manufacturing-facility-capital-investment